| Record ID | ia:bioindustryethic0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/bioindustryethic0000unse/bioindustryethic0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/bioindustryethic0000unse/bioindustryethic0000unse_meta.mrc |
LEADER: 00847cam 22002538a 4500
001 2005040638
003 DLC
005 20050224095518.0
008 050202s2005 mau 000 0 eng
010 $a 2005040638
020 $a0123693705 (alk. paper)
040 $aDLC$cDLC
042 $apcc
050 00 $aHD9999.B442$bB542 2005
082 00 $a174/.96606$222
245 00 $aBioIndustry ethics /$cDavid L. Finegold ... [et al.].
260 $aBoston, Mass. :$bElsevier Academic Press,$c2005.
263 $a0504
300 $ap. cm.
504 $aIncludes bibliographical references and index.
650 0 $aBiotechnology industries$xMoral and ethical aspects$vCase studies.
650 0 $aPharmaceutical industry$xMoral and ethical aspects$vCase studies.
650 0 $aBusiness ethics$xMoral and ethical aspects$vCase studies.
700 1 $aFinegold, David.